Scholarlink

Rationale <p>A potential strategy for managing morphine addiction is preventing mitogen-activated protein kinases (MAPKs) activation and neuroinflammation. The molecular basis of inflammation involves inflammatory cytokines, whose production and activity are modulated by the MAPKs signaling pathways.</p> Objectives <p>This study investigated how alpha-pinene (APN), an anti-inflammatory monoterpene, influences hippocampal MAPKs levels during chronic morphine exposure and the subsequent prolonged withdrawal phase.</p> Methods <p>Three experimental groups as dependent model groups intraperitoneally received 10 days of saline + DMSO, morphine (10&#xa0;mg/kg) + DMSO, and morphine + APN (20&#xa0;mg/kg). Three additional groups were designated as withdrawal models, treating them with either saline (group 1) or morphine (groups 2 and 3) for 10 days before subjecting them to a 30-day withdrawal period. During the withdrawal, the first and second groups were administered daily 5% DMSO injections, whereas the third group received daily APN (20&#xa0;mg/kg) treatment. <i>Results</i>: The results revealed that Hippocampal expression of MAPKs, including p38, ERK1/2, and JNK remained largely unchanged subsequent to both the chronic morphine exposure and the 30-day morphine wash-out phase. However, hippocampal levels of the phosphorylated form of the MAPKs significantly increased after both the morphine exposure and withdrawal phase. Interestingly, APN treatment during morphine exposure or over the 30-day of withdrawal phase significantly restored hippocampal levels of the phosphorylated MAPKs and decreased c-Fos expression.</p> Conclusions <p>It can be concluded that APN treatment may contribute to preventing hippocampal MAPK overactivation and decreasing c-Fos expression resulting from chronic morphine exposure and the subsequent withdrawal phase.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Alpha-pinene modulates hippocampal MAPKs/c-Fos pathways during morphine dependence and withdrawal in rats

  • 期刊论文

  • 发表日期：

    2026年2月28日

查看全文
  • Shamseddin Ahmadi,
  • Shnya Dlshad Taeeb,
  • Hawsar Rashid Ahmed,
  • Bestan Yousif Abdullah,
  • Mohammad Majidi

摘要

Rationale

A potential strategy for managing morphine addiction is preventing mitogen-activated protein kinases (MAPKs) activation and neuroinflammation. The molecular basis of inflammation involves inflammatory cytokines, whose production and activity are modulated by the MAPKs signaling pathways.

Objectives

This study investigated how alpha-pinene (APN), an anti-inflammatory monoterpene, influences hippocampal MAPKs levels during chronic morphine exposure and the subsequent prolonged withdrawal phase.

Methods

Three experimental groups as dependent model groups intraperitoneally received 10 days of saline + DMSO, morphine (10 mg/kg) + DMSO, and morphine + APN (20 mg/kg). Three additional groups were designated as withdrawal models, treating them with either saline (group 1) or morphine (groups 2 and 3) for 10 days before subjecting them to a 30-day withdrawal period. During the withdrawal, the first and second groups were administered daily 5% DMSO injections, whereas the third group received daily APN (20 mg/kg) treatment. Results: The results revealed that Hippocampal expression of MAPKs, including p38, ERK1/2, and JNK remained largely unchanged subsequent to both the chronic morphine exposure and the 30-day morphine wash-out phase. However, hippocampal levels of the phosphorylated form of the MAPKs significantly increased after both the morphine exposure and withdrawal phase. Interestingly, APN treatment during morphine exposure or over the 30-day of withdrawal phase significantly restored hippocampal levels of the phosphorylated MAPKs and decreased c-Fos expression.

Conclusions

It can be concluded that APN treatment may contribute to preventing hippocampal MAPK overactivation and decreasing c-Fos expression resulting from chronic morphine exposure and the subsequent withdrawal phase.